GRCE
Grace Therapeutics
GRCE
GRCE
33 hedge funds and large institutions have $12.6M invested in Grace Therapeutics in 2019 Q4 according to their latest regulatory filings, with 15 funds opening new positions, 8 increasing their positions, 4 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
0.04% more ownership
Funds ownership: 0.09% → 0.13% (+0.04%)
Holders
33
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$1.52M | |
| 2 | +$676K | |
| 3 | +$538K | |
| 4 |
Morgan Stanley
New York
|
+$412K |
| 5 |
Barclays
London,
United Kingdom
|
+$245K |
Top Sellers
| 1 | -$189K | |
| 2 | -$95K | |
| 3 | -$46K | |
| 4 |
ARTA
A.R.T. Advisors
New York
|
-$41K |
| 5 |
PAG
Private Advisor Group
Morristown,
New Jersey
|
-$36.8K |